InvestorsHub Logo
Followers 155
Posts 2683
Boards Moderated 0
Alias Born 01/29/2004

Re: georgejjl post# 374853

Saturday, 09/24/2022 6:20:35 PM

Saturday, September 24, 2022 6:20:35 PM

Post# of 470860
Similar Price and Long-Term Value Projections

Dawson James also issued estimates for Anavex Life Sciences
Q4 2022 earnings at ($0.14) EPS
FY2022 earnings at ($0.57) EPS
FY2023 earnings at $0.78 EPS
FY2024 earnings at $15.23 EPS
FY2025 earnings at $19.52 EPS
FY2026 earnings at $19.88 EPS.



Interesting; these are very much in line with what I've projected on my AVXL values spreadsheet. I just added some adjacent columns: a share price column (20x the earnings per share), a column stating the number of AVXL shares I own, their total value each coming year, and finally total annual dividends, estimating, variously, percent of earnings that will go out as dividends.

If Anavex goes bust (won't happen), I'll have lost all of the discretionary dollars I've used over the years to accumulate my several thousand shares ($2.91 cost basis). But if the company can attain annual revenues of even a fraction of those Dawson James and I, independently, have marked up, I will be well-rewarded. If the annual revenues turn out to yield the indicated earnings per share (EPS), I, (well, my estate), will be rather wealthy in a few years.

Those contemplating the taking or holding of a no-trading, long term AVXL investment position should run all of the relevant numbers; similar to those here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News